Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katharine Harding

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Nurse Educator|January 20, 2026
Mapping the Landscape of Academic Support in Nursing Education: A Scoping ReviewSuzanne M Sutton, Sevilla L Bronson, Katharine Harding
Neurology|January 15, 2020
Multiple cause of death analysis in multiple sclerosis: A population-based studyKatharine Harding, Feng Zhu, Mohammed Alotaibi, et al.
Neuroscience Letters|June 27, 2012
Genotype-phenotype correlation for non-HLA disease associated risk alleles in multiple sclerosisKatharine Harding, Gillian Ingram, Mark Cossburn, et al.
Seizure|October 3, 2022
Exploring seizure management in hospitals, unmet need, and the impact of the COVID-19 pandemic on seizure presentations to hospitalBethan Ellis, Ellie Chilcott, Keri John, et al.
Journal of Clinical Epidemiology|June 15, 2015
A longitudinal model for disease progression was developed and applied to multiple sclerosisMichael Lawton, Kate Tilling, Neil Robertson, et al.
Health Technology Assessment (Winchester, England)|November 8, 2016
Modelling disease progression in relapsing-remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohortKate Tilling, Michael Lawton, Neil Robertson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 11, 2016
Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorderSvetlana Hakobyan, Sebastian Luppe, David Rs Evans, et al.
Multiple Sclerosis and Related Disorders|August 13, 2018
A contemporary study of mortality in the multiple sclerosis population of south east WalesKatharine Harding, Valerie Anderson, Owain Williams, et al.
Neurology|December 18, 2012
Clinical relevance of differential lymphocyte recovery after alemtuzumab therapy for multiple sclerosisMark D Cossburn, Katharine Harding, Gillian Ingram, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2016
Complement Biomarkers as Predictors of Disease Progression in Alzheimer's DiseaseSvetlana Hakobyan, Katharine Harding, Mohammed Aiyaz, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Nurse Educator|January 20, 2026
Mapping the Landscape of Academic Support in Nursing Education: A Scoping ReviewSuzanne M Sutton, Sevilla L Bronson, Katharine Harding
Neurology|January 15, 2020
Multiple cause of death analysis in multiple sclerosis: A population-based studyKatharine Harding, Feng Zhu, Mohammed Alotaibi, et al.
Neuroscience Letters|June 27, 2012
Genotype-phenotype correlation for non-HLA disease associated risk alleles in multiple sclerosisKatharine Harding, Gillian Ingram, Mark Cossburn, et al.
Seizure|October 3, 2022
Exploring seizure management in hospitals, unmet need, and the impact of the COVID-19 pandemic on seizure presentations to hospitalBethan Ellis, Ellie Chilcott, Keri John, et al.
Journal of Clinical Epidemiology|June 15, 2015
A longitudinal model for disease progression was developed and applied to multiple sclerosisMichael Lawton, Kate Tilling, Neil Robertson, et al.
Health Technology Assessment (Winchester, England)|November 8, 2016
Modelling disease progression in relapsing-remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohortKate Tilling, Michael Lawton, Neil Robertson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 11, 2016
Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorderSvetlana Hakobyan, Sebastian Luppe, David Rs Evans, et al.
Multiple Sclerosis and Related Disorders|August 13, 2018
A contemporary study of mortality in the multiple sclerosis population of south east WalesKatharine Harding, Valerie Anderson, Owain Williams, et al.
Neurology|December 18, 2012
Clinical relevance of differential lymphocyte recovery after alemtuzumab therapy for multiple sclerosisMark D Cossburn, Katharine Harding, Gillian Ingram, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2016
Complement Biomarkers as Predictors of Disease Progression in Alzheimer's DiseaseSvetlana Hakobyan, Katharine Harding, Mohammed Aiyaz, et al.
Pageof 2